STARBRITE: A Randomized Pilot Trial of BNP-Guided Therapy in Patients With Advanced Heart Failure
NCT00484770 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 135
Last updated 2023-11-15
Summary
The primary hypothesis is that, in patients with advanced heart failure, an outpatient fluid management strategy guided by BNP levels and clinical targets will lead to fewer days hospitalized or dead over a 3-month period compared to an outpatient fluid management strategy using clinical targets alone.
Conditions
- Congestive Heart Failure
Interventions
- DEVICE
-
Brain Natriuretic Peptide Levels -- Diagnostic testing
- OTHER
-
clinical assessment
Sponsors & Collaborators
- collaborator OTHER
- lead OTHER
Principal Investigators
-
Monica R Shah, MD · Duke University Medical Center/Washington Hospital Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-02-28
- Completion
- 2005-08-31
More Related Trials
-
A Study of Two Doses of Intravenous NATRECOR hBNP (Nesiritide) in Patients With Worsening Congestive Heart Failure Who Have Difficulty Breathing at Rest
NCT00288730 ·Status: COMPLETED ·Phase: PHASE3
-
Biomarkers in Acute Heart Failure
NCT00537628 ·Status: COMPLETED
-
Study to Assess Hemodynamic Effects, Safety and Tolerability of Chimeric Natriuretic Peptide (CD-NP) in Patients With Stabilized Acute Heart Failure (AHF)
NCT00699712 ·Status: COMPLETED ·Phase: PHASE2
-
ZP120 Add-on to Furosemide in Treatment of Acute or Sub-Acute Decompensated Heart Failure
NCT00283361 ·Status: TERMINATED ·Phase: PHASE2
-
Product Design Clinical Performance Study of sc2Wear Furosemide Combination Product
NCT02804282 ·Status: COMPLETED ·Phase: PHASE3
-
Recombinant BNP on Heart and Renal Function in Acute Heart Failure
NCT01625403 ·Status: UNKNOWN ·Phase: PHASE2
-
Pilot Study for First Clinical Use of sc2Wear Furosemide Combination Product
NCT02804035 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of BNP and NT-proBNP in the Management of Patients With Chronic and Acute Heart Failure
NCT04107220 ·Status: UNKNOWN ·Phase: NA
-
Polydiuretic Therapy for Heart Failure With Preserved Ejection Fraction and Diabetes Mellitus
NCT04697485 ·Status: WITHDRAWN ·Phase: PHASE4
-
BNP for Cardio-Renal Decompensation Syndrome (BNP-CARDS)
NCT00186329 ·Status: COMPLETED ·Phase: PHASE4
-
Neutrophil Gelatinase-Associated Lipcalin (NGAL) Evaluation Along With B-Type Natriuretic Peptide in Acutely Decompensated HF
NCT00693745 ·Status: COMPLETED
-
Inhaled Sodium Nitrite on Heart Failure With Preserved Ejection Fraction
NCT02262078 ·Status: COMPLETED ·Phase: PHASE2
-
Preliminary Study on the Clinical Effect of Recombinant Human Brain Natriuretic Peptide on Sepsis Complicated With Heart Failure
NCT05111769 ·Status: UNKNOWN ·Phase: NA
-
Combination Diuretic Therapy for Acute Decompensated Heart Failure
NCT05840536 ·Status: WITHDRAWN ·Phase: PHASE4
-
Soluble ST2 in Patients With Heart Failure"
NCT06426368 ·Status: NOT_YET_RECRUITING
-
Targeting Acute Congestion With Tolvaptan in Congestive Heart Failure
NCT01644331 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Effects of 4 Weeks Treatment With Subcutaneous Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Preserved Ejection Fraction
NCT02814097 ·Status: COMPLETED ·Phase: PHASE2
-
Intravenous Vasodilator vs. Inotropic Therapy in Patients With Heart Failure
NCT02767024 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Safety Study Comparing Natrecor (Nesiritide) Versus Dobutamine Therapy for Worsening Congestive Heart Failure
NCT00270400 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone
NCT00391846 ·Status: COMPLETED ·Phase: PHASE4
-
Sub-Q Versus IV Furosemide in Acute Heart Failure
NCT02579057 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Predicting Successful Sleep Apnea Treatment With Acetazolamide in Heart Failure Patients
NCT01377987 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Outpatient Intravenous Diuretic Therapy for Treatment of Worsening Heart Failure (OUTPATIENT-WHF)
NCT05704595 ·Status: WITHDRAWN ·Phase: NA
-
Safety, Tolerability and Efficacy of Rapid Optimization, Helped by NT-proBNP testinG, of Heart Failure Therapies
NCT03412201 ·Status: UNKNOWN ·Phase: NA
-
SGLT-2 Inhibitor and High-Dose Furosemide Plus Small-Volume Hypertonic Saline Solution in Acute HF
NCT06442280 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4